drugset / Trial / NCT04655716
Urine Alkalinisation to Prevent AKI in COVID-19
RandomizedParallel-groupOpen-labelTreatment
Summary
The aim is to explore the feasibility and safety of urine alkalinisation in critically ill patients with COVID-19.
Timeline
- Start
- 2021-07-19
- Primary completion
- 2022-06-30
- Completion
- 2022-12-31
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | sodium bicarbonate | Diagnostic / imaging agent | 150 meq | Intravenous |